Literature DB >> 17169338

Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, at mammalian cells expressing the dopamine transporter.

Okechukwu T Ukairo1, Suneetha Ramanujapuram, Christopher K Surratt.   

Abstract

Cocaine, amphetamines and other psychostimulants inhibit synaptic dopamine uptake by interfering with dopamine transporter (DAT) function. The resultant potentiation of dopaminergic neurotransmission is associated with psychostimulant addiction. Fluctuations in dopamine uptake inhibition potency (DUIP) were observed for classical DAT blockers including cocaine, mazindol, methylphenidate (Ritalintrade mark) and benztropine in CHO cells expressing wild type DAT; cocaine potency also decreased in DAT-expressing non-neuronal COS-7 cells and neuronal N2A neuroblastoma cells. In contrast, the DAT substrate (+)-amphetamine did not display this DUIP fluctuation. In parallel experiments, no fluctuation was observed for the apparent binding affinities of these 5 drugs. The DUIP decrease appeared to correlate with an increase in cell surface DAT expression level, as measured by B(max) values and confocal microscopy. The fact that the DUIP profile of amphetamine diverged from that of the classical DAT blockers is consistent with the idea of fundamental differences between the mechanisms of abused psychostimulant DAT substrates and inhibitors. Identification of the cellular factors that underlie the DAT inhibitor DUIP fluctuation phenomenon may be relevant to anti-psychostimulant drug discovery efforts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169338      PMCID: PMC1855629          DOI: 10.1016/j.brainres.2006.11.018

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  33 in total

1.  N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization.

Authors:  Charlotta Granas; Jasmine Ferrer; Claus Juul Loland; Jonathan A Javitch; Ulrik Gether
Journal:  J Biol Chem       Date:  2002-12-02       Impact factor: 5.157

2.  Generation of an activating Zn(2+) switch in the dopamine transporter: mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle.

Authors:  Claus Juul Loland; Lene Norregaard; Thomas Litman; Ulrik Gether
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

3.  Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.

Authors:  C Saunders; J V Ferrer; L Shi; J Chen; G Merrill; M E Lamb; L M Leeb-Lundberg; L Carvelli; J A Javitch; A Galli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  Cocaine increases dopamine uptake and cell surface expression of dopamine transporters.

Authors:  Lynette C Daws; Paul D Callaghan; José A Morón; Kris M Kahlig; Toni S Shippenberg; Jonathan A Javitch; Aurelio Galli
Journal:  Biochem Biophys Res Commun       Date:  2002-02-08       Impact factor: 3.575

5.  Dopamine transporters are phosphorylated on N-terminal serines in rat striatum.

Authors:  James D Foster; Benchaporn Pananusorn; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

6.  The human dopamine transporter forms a tetramer in the plasma membrane: cross-linking of a cysteine in the fourth transmembrane segment is sensitive to cocaine analogs.

Authors:  Hanne Hastrup; Namita Sen; Jonathan A Javitch
Journal:  J Biol Chem       Date:  2003-09-30       Impact factor: 5.157

7.  Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter.

Authors:  H H Sitte; S Huck; H Reither; S Boehm; E A Singer; C Pifl
Journal:  J Neurochem       Date:  1998-09       Impact factor: 5.372

8.  Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.

Authors:  Wenfei Wang; Mark S Sonders; Okechukwu T Ukairo; Helen Scott; Megan K Kloetzel; Christopher K Surratt
Journal:  Mol Pharmacol       Date:  2003-08       Impact factor: 4.436

9.  Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy.

Authors:  Tatiana Sorkina; Suzanne Doolen; Emilia Galperin; Nancy R Zahniser; Alexander Sorkin
Journal:  J Biol Chem       Date:  2003-05-13       Impact factor: 5.157

10.  Decreased plasma membrane expression of striatal dopamine transporter in aging.

Authors:  Michael F Salvatore; Subbu Apparsundaram; Greg A Gerhardt
Journal:  Neurobiol Aging       Date:  2003-12       Impact factor: 4.673

View more
  8 in total

1.  Dopamine transporter oligomerization: impact of combining protomers with differential cocaine analog binding affinities.

Authors:  Juan Zhen; Tamara Antonio; Shu-Yuan Cheng; Solav Ali; Kymry T Jones; Maarten E A Reith
Journal:  J Neurochem       Date:  2015-01-26       Impact factor: 5.372

2.  Site-directed mutations near transmembrane domain 1 alter conformation and function of norepinephrine and dopamine transporters.

Authors:  Bipasha Guptaroy; Rheaclare Fraser; Aalisha Desai; Minjia Zhang; Margaret E Gnegy
Journal:  Mol Pharmacol       Date:  2010-12-13       Impact factor: 4.436

Review 3.  In vitro study methodologies to investigate genetic aspects and effects of drugs used in attention-deficit hyperactivity disorder.

Authors:  Edna Grünblatt; Jasmin Bartl; Zoya Marinova; Susanne Walitza
Journal:  J Neural Transm (Vienna)       Date:  2012-07-26       Impact factor: 3.575

4.  Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian Poisons.

Authors:  Thomas M Jeitner; Mike Kalogiannis; Boris F Krasnikov; Irving Gomolin; Morgan R Peltier; Graham R Moran
Journal:  Toxicol Sci       Date:  2016-03-29       Impact factor: 4.849

5.  Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats.

Authors:  Keri A Chiodo; Christopher M Läck; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2008-07-06       Impact factor: 4.530

6.  3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture.

Authors:  Jack W Lipton; Emeline G Tolod; Valerie B Thompson; Lin Pei; Katrina L Paumier; Brian T Terpstra; Kaari A Lynch; Timothy J Collier; Caryl E Sortwell
Journal:  Neuropharmacology       Date:  2008-07-04       Impact factor: 5.250

7.  Hypocretin receptor 1 knockdown in the ventral tegmental area attenuates mesolimbic dopamine signaling and reduces motivation for cocaine.

Authors:  David L Bernstein; Preeti S Badve; Jessica R Barson; Caroline E Bass; Rodrigo A España
Journal:  Addict Biol       Date:  2017-10-02       Impact factor: 4.280

8.  Unusual effects of nicotine as a psychostimulant on ambulatory activity in mice.

Authors:  Toyoshi Umezu
Journal:  ISRN Pharmacol       Date:  2012-03-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.